Vikram Singh Bajaj
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vikram Singh Bajaj.
Scientific Reports | 2017
Daniel J. Kennedy; Scott J. Seltzer; Ricardo Jiménez-Martínez; Hattie L. Ring; Nicolas S. Malecek; Svenja Knappe; Elizabeth A. Donley; John Kitching; Vikram Singh Bajaj; Alexander Pines
Low thermal-equilibrium nuclear spin polarizations and the need for sophisticated instrumentation render conventional nuclear magnetic resonance (NMR) spectroscopy and imaging (MRI) incompatible with small-scale microfluidic devices. Hyperpolarized 129Xe gas has found use in the study of many materials but has required very large and expensive instrumentation. Recently a microfabricated device with modest instrumentation demonstrated all-optical hyperpolarization and detection of 129Xe gas. This device was limited by 129Xe polarizations less than 1%, 129Xe NMR signals smaller than 20 nT, and transport of hyperpolarized 129Xe over millimeter lengths. Higher polarizations, versatile detection schemes, and flow of 129Xe over larger distances are desirable for wider applications. Here we demonstrate an ultra-sensitive microfabricated platform that achieves 129Xe polarizations reaching 7%, NMR signals exceeding 1 μT, lifetimes up to 6 s, and simultaneous two-mode detection, consisting of a high-sensitivity in situ channel with signal-to-noise of 105 and a lower-sensitivity ex situ detection channel which may be useful in a wider variety of conditions. 129Xe is hyperpolarized and detected in locations more than 1 cm apart. Our versatile device is an optimal platform for microfluidic magnetic resonance in particular, but equally attractive for wider nuclear spin applications benefitting from ultra-sensitive detection, long coherences, and simple instrumentation.
Science Translational Medicine | 2018
Alice Chen-Plotkin; Roger L. Albin; Roy N. Alcalay; Debra Babcock; Vikram Singh Bajaj; Dubois Bowman; Alex Buko; Jesse M. Cedarbaum; Daniel Chelsky; Mark R. Cookson; Ted M. Dawson; Richard B. Dewey; Tatiana Foroud; Mark Frasier; Dwight C. German; Katrina Gwinn; Xuemei Huang; Catherine Kopil; Thomas Kremer; Shirley Lasch; Ken Marek; Jarrod A. Marto; Kalpana M. Merchant; Brit Mollenhauer; Anna Naito; Judith A. Potashkin; Alyssa Reimer; Liana S. Rosenthal; Rachel Saunders-Pullman; Clemens R. Scherzer
The recent advent of an “ecosystem” of shared biosample biorepositories and data sets will aid efforts to define biomarkers for Parkinson’s disease. The recent advent of an “ecosystem” of shared biofluid sample biorepositories and data sets will focus biomarker efforts in Parkinson’s disease, boosting the therapeutic development pipeline and enabling translation with real-world impact.
Archive | 2016
Victor Marcel Acosta; Vikram Singh Bajaj; Jason Donald Thompson; Eric Peeters
Archive | 2013
Andrew Conrad; Eric Peeters; Vikram Singh Bajaj; Jason Donald Thompson; Mark Askew
Archive | 2013
Andrew Conrad; Eric Peeters; Vikram Singh Bajaj; Jason Donald Thompson; Mark Askew
Archive | 2014
Andrew Conrad; Eric Peeters; Vikram Singh Bajaj; Jason Donald Thompson; Mark Askew
Archive | 2016
Jerrod Joseph Schwartz; Jason Donald Thompson; Vikram Singh Bajaj
Archive | 2016
Vikram Singh Bajaj; Vasiliki Demas; Victor Marcel Acosta; James Higbie; John D. Perreault; Michael Brundage; Chinmay Belthangady
Archive | 2015
Jason Donald Thompson; Vikram Singh Bajaj; Victor Marcel Acosta; Tamara Lynn Troy
Archive | 2015
Andrew Homyk; Victor Marcel Acosta; Vikram Singh Bajaj